441 related articles for article (PubMed ID: 26169615)
1. Phase II Study of Lapatinib in Combination With Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: Clinical Outcomes and Predictive Value of Early [18F]Fluorodeoxyglucose Positron Emission Tomography Imaging (TBCRC 003).
Lin NU; Guo H; Yap JT; Mayer IA; Falkson CI; Hobday TJ; Dees EC; Richardson AL; Nanda R; Rimawi MF; Ryabin N; Najita JS; Barry WT; Arteaga CL; Wolff AC; Krop IE; Winer EP; Van den Abbeele AD
J Clin Oncol; 2015 Aug; 33(24):2623-31. PubMed ID: 26169615
[TBL] [
